PDF - Presentation for Media & Analysts - Acino

More documents

Recommendations

Info

R&D highlights 2012 Pipeline including former Mepha projects further streamlined to also fulfill BtC needs Several projects for micro tablets and stick packs Sildenafil pellets in stick packs 4 food supplements (micro tablets in capsules) to be submitted in 2013 18
R&D highlights 2012 Technology base and expertise for special formulations and drug delivery systems further broadened Further strengthening of implant platform US-FDA agreement regarding harmonized clinical study design for US and EU Leuprorelin: Identification of potential partners progressing well Goserelin 1M: Study ongoing Goserelin 3M: Study start only after completion of 1M study 19
Page 1 and 2: Acino - Delivering Health Annual Re
Page 3 and 4: 2012 Key financials (in EUR million
Page 5 and 6: 2012 EBITDA acquisition related one
Page 7 and 8: 2012 Cash flow (EUR million) 2012 2
Page 9 and 10: 2012 revenue and contribution by re
Page 11 and 12: Segment Business to Business Focus:
Page 13 and 14: Segment Production Supplies other s
Page 15 and 16: Syndication financing terms Facilit
Page 17: R&D highlights 2012 Development for
Page 21 and 22: Acino makes use of synergies in var
Page 23 and 24: Acino’s estimated approval dates
Page 25 and 26: Acino’s growth drivers Fully expl
Page 27 and 28: Acino Switzerland Brands ® 27
Page 29 and 30: Acino Switzerland - rolling out por
Page 31 and 32: Optimizing BtB concept Price Pressu
Page 33 and 34: The “new” Acino: broad customer
Page 35 and 36: Outlook 2013 and mid-term expectati
Page 37: Acino - Delivering Health Thank you

PDF - Presentation for Media & Analysts - Acino

Create successful ePaper yourself

Delete template?

Save as template?